Science Progress | Where science, technology, and progressive policy meet

LIFE SCIENCES

Thrown Back to the 90’s

The misguided human embryonic stem cell research ruling by a U.S. court would discontinue amazing gains made over the past 12 years in regenerative medicine.

Financing Innovation

A Win for Regional Innovation

On August 24th the Department of Energy Announced that a consortium of 90 organizations anchored at Penn State University will receive $129 million of to support energy efficiency innovation.

And… We’re Back.

After almost three years on the project, our faithful managing editor Andrew Pratt has moved on to join Teach for America. We wish him the best. My name is Sean Pool, and I’ll be filling in as interim managing editor [...]

LIFE SCIENCES

Drug Regulation in all the Wrong Places

The FDA’s myopic focus on early-stage testing and lack of emphasis on phase four human clinical trials has led to many safety-related drug recalls in recent years, meriting a reexamination of our regulatory system.

LIFE SCIENCES

One Small Step for Embryonic Stem Cells

The Food and Drug Administration approves the first clinical trial for embryonic stem cell treatment in patients with recent spinal cord injuries—creating a much needed regulatory pathway.